T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 3179399)

Published in Blood on August 02, 2011

Authors

Michael N Alonso1, Michael T Wong, Angela L Zhang, Daniel Winer, Megan M Suhoski, Lorna L Tolentino, Juliana Gaitan, Matthew G Davidson, Tiffany H Kung, David M Galel, Kari C Nadeau, Jinah Kim, Paul J Utz, Kalle Söderström, Edgar G Engleman

Author Affiliations

1: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Articles citing this

Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS One (2015) 1.46

The effects of TLR activation on T-cell development and differentiation. Clin Dev Immunol (2012) 1.33

T cells out of control--impaired immune regulation in the inflamed joint. Nat Rev Rheumatol (2013) 1.14

Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand. Nat Commun (2014) 0.97

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. Ann Rheum Dis (2015) 0.97

The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis. Front Immunol (2015) 0.92

Th17 cells induce Th1-polarizing monocyte-derived dendritic cells. J Immunol (2013) 0.87

Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer. J Biomed Biotechnol (2012) 0.82

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice. Pharmaceuticals (Basel) (2017) 0.79

Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation. J Neuroimmune Pharmacol (2015) 0.77

In vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cells. PLoS One (2013) 0.77

Depletion of inflammatory dendritic cells with anti-CD209 conjugated to saporin toxin. Immunol Res (2014) 0.76

Differential mucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults. Immunol Cell Biol (2016) 0.76

Identification and Characterization of Two Human Monocyte-Derived Dendritic Cell Subpopulations with Different Functions in Dying Cell Clearance and Different Patterns of Cell Death. PLoS One (2016) 0.75

Immunoproteomic identification and characterization of Ni(2+)-regulated proteins implicates Ni(2+) in the induction of monocyte cell death. Cell Death Dis (2017) 0.75

Articles cited by this

Dendritic cells and the control of immunity. Nature (1998) 56.54

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med (1994) 21.52

A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61

Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med (2006) 14.33

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol (2007) 13.70

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell (1997) 12.68

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol (2008) 9.64

Pathogenesis and therapy of psoriasis. Nature (2007) 6.94

A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol (2008) 6.09

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 6.04

Atopic dermatitis. N Engl J Med (2008) 5.92

TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med (2005) 5.77

Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol (2003) 5.54

Langerhans cells arise from monocytes in vivo. Nat Immunol (2006) 5.46

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity (2007) 4.70

Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65

Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med (2008) 4.30

Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol (2008) 4.18

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med (2004) 4.02

Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science (2008) 3.97

Signaling and transcription in T helper development. Annu Rev Immunol (2000) 3.44

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88

Dendritic cell subsets in health and disease. Immunol Rev (2007) 2.45

Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol (2001) 2.43

Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med (2008) 2.41

Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol (2008) 2.19

DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol (2002) 2.16

Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol (2002) 2.16

Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol (1999) 2.07

Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol (1998) 2.05

Memory B and memory plasma cells. Immunol Rev (2010) 1.95

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol (2008) 1.90

Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med (2009) 1.66

Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol (2007) 1.60

HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J Leukoc Biol (2003) 1.18

Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum (2008) 1.14

NKT cells direct monocytes into a DC differentiation pathway. J Leukoc Biol (2007) 1.11

Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Eur J Immunol (2008) 1.10

Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGN. J Leukoc Biol (2009) 1.10

Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci (2009) 1.04

Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood (2007) 1.03

T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol (1999) 0.92

Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes. Eur J Immunol (1995) 0.90

T-cell-mediated and antigen-dependent differentiation of human monocyte into different dendritic cell subsets: a feedback control of Th1/Th2 responses. FASEB J (2008) 0.85

Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells. Cancer Res (2002) 0.83

Expression and regulation of human CD275 on endothelial cells in healthy and inflamed mucosal tissues. Scand J Immunol (2006) 0.78

Recalling the year in memory T cells. Ann N Y Acad Sci (2008) 0.76

Articles by these authors

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet (2006) 15.99

Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32

Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 8.15

Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol (2002) 7.03

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci U S A (2009) 5.36

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med (2011) 5.16

Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science (2013) 5.06

Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med (2009) 4.71

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65

Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors. Proc Natl Acad Sci U S A (2003) 4.57

Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med (2002) 4.54

RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature (2007) 4.35

Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med (2008) 4.04

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res (2011) 3.81

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med (2004) 3.17

Proteome-wide analysis in Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective binding modules of histone H3 methylated at either lysine 4 or lysine 36. J Biol Chem (2006) 3.14

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol (2003) 2.80

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med (2008) 2.64

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood (2002) 2.52

The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci Transl Med (2010) 2.40

Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol (2010) 2.36

Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nat Immunol (2008) 2.34

Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum (2005) 2.30

Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood (2007) 2.29

Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest (2006) 2.10

Protein microarrays with carbon nanotubes as multicolor Raman labels. Nat Biotechnol (2008) 2.08

Induced immune tolerance for kidney transplantation. N Engl J Med (2011) 2.08

Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling. Nat Immunol (2010) 2.07

Obesity predisposes to Th17 bias. Eur J Immunol (2009) 2.04

Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol (2010) 1.99

The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity (2010) 1.97

Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med (2004) 1.89

Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol (2007) 1.86

CD28 costimulation is essential for human T regulatory expansion and function. J Immunol (2008) 1.86

Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood (2008) 1.80

Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol (2006) 1.79

The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10. Adv Anat Pathol (2010) 1.76

Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol (2013) 1.75

Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse. J Exp Med (2007) 1.70

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med (2002) 1.67

Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res (2006) 1.64

Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol (2014) 1.61

The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood (2011) 1.57

Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol (2011) 1.57

4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. J Immunol (2007) 1.57

IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest (2008) 1.55

Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol (2012) 1.51

Spindle cell neoplasms encountered in dermatologic surgery: a review. Dermatol Surg (2012) 1.50

Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2013) 1.49

Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies. Arthritis Res Ther (2012) 1.49

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest (2004) 1.44

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol (2008) 1.43

Systemic panniculitis-like T-cell lymphoma with involvement of mesenteric fat and subcutis. J Cutan Pathol (2014) 1.42

Identification of a putative regulator of early T cell activation genes. Science. 1988. 241: 202-205. J Immunol (2010) 1.41

Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J Virol (2002) 1.40

Protein microarrays address the elephant in the room. Clin Chem (2008) 1.39

IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J Immunol (2009) 1.33

Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol (2006) 1.32

Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. Endocrinology (2004) 1.31

Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat Commun (2011) 1.30

Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch Allergy Immunol (2010) 1.29

Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res (2010) 1.27

Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. J Allergy Clin Immunol (2013) 1.25

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest (2002) 1.24

Exploiting the reversible covalent bonding of boronic acids: recognition, sensing, and assembly. Acc Chem Res (2012) 1.21

XB130, a novel adaptor protein, promotes thyroid tumor growth. Am J Pathol (2010) 1.21

On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions. Nat Med (2012) 1.17

In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood (2002) 1.16

Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease. BMC Med Genomics (2008) 1.16

Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum (2008) 1.14

New tools for classification and monitoring of autoimmune diseases. Nat Rev Rheumatol (2012) 1.13

Free-solution oligonucleotide separation in nanoscale channels. Anal Chem (2007) 1.13

An array of possibilities for the study of autoimmunity. Nature (2005) 1.12

Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci U S A (2010) 1.11

Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nat Chem Biol (2012) 1.10

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Transl Med (2011) 1.10

Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconjug Chem (2007) 1.09

Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res (2002) 1.08

Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther (2009) 1.07

Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood (2005) 1.07

Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol (2002) 1.06

Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest (2013) 1.05

Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics (2003) 1.04

Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. J Exp Med (2002) 1.04

A new two-color Fab labeling method for autoantigen protein microarrays. Nat Methods (2006) 1.04

Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J Virol (2003) 1.04

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology (2007) 1.03

Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood (2007) 1.03

In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines. Mol Pharm (2009) 1.02

Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma. J Allergy Clin Immunol (2009) 1.02

An enantioselective fluorescent sensor for sugar acids. J Am Chem Soc (2004) 1.02

Adoptive immunotherapy: good habits instilled at youth have long-term benefits. Immunol Res (2008) 1.02